SEC Form 4 · accession 0001209191-19-000589
Alaunos Therapeutics, Inc. · TCRT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Douglas W. Pagan
Director
Period of report
Dec 31, 2018
Accepted (ET)
Jan 2, 2019 · 9:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001107421
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 31, 2018 | A | 40,107 | $0.00 | A | 40,107 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $1.87 | Dec 31, 2018 | A | 63,350 | A | — | Dec 31, 2028 | Common Stock | 63,350 | 63,350 | D |
Explanation of responses
- F140,107 shares vest on 12/31/2019.
- F263,350 options vest on 12/31/2019.